J Gastric Cancer.  2011 Mar;11(1):38-45.

Bone Metastasis in Gastric Cancer Patients

• Ahn JB
• Ha TK
• Kwon SJ

Abstract

PURPOSE
Bone metastasis from stomach cancer occurs only rarely and it is known to have a very poor prognosis. This study examined the clinical characteristics and prognosis of patients who were diagnosed with stomach cancer and bone metastasis.
MATERIALS AND METHODS
The subjects were 19 patients who were diagnosed with stomach cancer at Hanyang University Medical Center from June 1992 to August 2010 and they also had bone metastasis. The survival rate according to many clinicopathologic factors was retrospectively analyzed.
RESULTS
11 patients out of 18 patients (61%) who received an operation were in stage IV and the most common bone metastasis location was the spine. Bone scintigraphy was mostly used for diagnosing bone metastasis and PET-CT and magnetic resonance imaging were used singly or together. The serum alkaline phosphatase at the time of diagnosis had increased in 12 cases and there were clinical symptoms (bone pain) in 16 cases. Treatment was given to 14 cases and it was mostly radiotherapy. There were 2 cases of discovering bone metastasis at the time of diagnosing stomach cancer. The interval after operation to the time of diagnosing bone metastasis for the 18 cases that received a stomach cancer operation was on average 14.9+/-17.3 months and the period until death after the diagnosis of bone metastasis was on average 3.8+/-2.6 months. As a result of univariate survival rate analysis, the group that was treated for bone metastasis had a significantly better survival period when the bone metastasis was singular rather than multiple, as compared to the non-treatment group, yet both factors were not independent prognosis factors on multivariate survival analysis.
CONCLUSIONS
An examination to confirm the status of bone metastasis when conducting a radio-tracer test after the initial diagnosis and also after an operation is needed for stomach cancer patients, and bone scintigraphy is the most helpfully modality. Making the diagnosis at the early stage and suitable treatments are expected to enhance the survival rate and improve the quality of life even for the patients with bone metastasis.

Keyword

Stomach neoplasms; Bone metastasis; Diagnosis; Prognosis

MeSH Terms

Academic Medical Centers
Alkaline Phosphatase
Humans
Magnetic Resonance Imaging
Neoplasm Metastasis
Prognosis
Quality of Life
Retrospective Studies
Spine
Stomach Neoplasms
Survival Rate
Alkaline Phosphatase

Figure

• 

  Fig. 1 Bone scintigraphy shows increased uptake in multifocal area.

• 

  Fig. 2 PET-CT shows increased uptake in the vertebra, paravertebral muscle.

Reference

1. Suh CI, Suh KA, Park SH, Chang HJ, Ko JW, Ahn DH. Annual report of the central cancer registry in Korea - 1998 (Based on Registered Data from 124 Hospitals). J Korean Cancer Assoc. 2000. 32:827–834.

2. Crivellari D, Carbone A, Sigon R, Buonadonna A, Cannizzaro R, Sorio R, et al. Gastric cancer with bone marrow invasion at presentation: case-report and review of the literature. Tumori. 1995. 81:74–76.

3. Noda N, Sano T, Shirao K, Ono H, Katai H, Sasako M, et al. A case of bone marrow recurrence from gastric carcinoma after a nine-year disease-free interval. Jpn J Clin Oncol. 1996. 26:472–475.

4. Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer. 1950. 3:74–85.

5. Pasquini E, Gianni L, Aitini E, Nicolini M, Fattori PP, Cavazzini G, et al. Acute disseminated intravascular coagulation syndrome in cancer patients. Oncology. 1995. 52:505–508.

6. Yoshikawa K, Kitaoka H. Bone metastasis of gastric cancer. Jpn J Surg. 1983. 13:173–176.

7. Nishidoi H, Koga S. Clinicopathological study of gastric cancer with bone metastasis. Gan To Kagaku Ryoho. 1987. 14(5 Pt 2):1717–1722.

8. Seto M, Tonami N, Koizumi K, Sui O, Hisada K. Bone metastasis in gastric cancer--clinical evaluation of bone scintigrams. Kaku Igaku. 1983. 20:795–801.

9. Choi CW, Lee DS, Chung JK, Lee MC, Kim NK, Choi KW, et al. Evaluation of bone metastases by Tc-99m MDP imaging in patients with stomach cancer. Clin Nucl Med. 1995. 20:310–314.

10. Kusumoto H, Haraguchi M, Nozuka Y, Oda Y, Tsuneyoshi M, Iguchi H. Characteristic features of disseminated carcinomatosis of the bone marrow due to gastric cancer: the pathogenesis of bone destruction. Oncol Rep. 2006. 16:735–740.

11. Wilner D. Wilner D, editor. Cancer metastasis to bone. Radiology of Bone Tumors and Allied Disorders. 1982. Vol 1. Philadelphia: WB Saunders;3641–3908.

12. Gold RI, Seeger LL, Bassett LW, Steckel RJ. An integrated approach to the evaluation of metastatic bone disease. Radiol Clin North Am. 1990. 28:471–483.

13. Corcoran RJ, Thrall JH, Kyle RW, Kaminski R, Johnson MC. Solitary abnormalities in bone scans of patients with extraosseous malignancies. Radiology. 1976. 121:663–667.

14. Shirazi PH, Rayudu GV, Fordham EW. Review of solitary 18F bone scan lesions. Radiology. 1974. 112:369–372.

15. Brown ML. Significance of the solitary lesion in pediatric bone scanning: concise communication. J Nucl Med. 1983. 24:114–115.

16. Rappaport AH, Hoffer PB, Genant HK. Unifocal bone findings by scintigraphy. Clinical significance in patients with known primary cancer. West J Med. 1978. 129:188–192.

17. Diel IJ, Kaufman M, Bastert G. Metastatic bone disease: fundamental and clinical aspects. 1994. 1st ed. Santa Clara: Springer-Verlag Telos;22–23.

18. McNeil BJ. Value of bone scanning in neoplastic disease. Semin Nucl Med. 1984. 14:277–286.

19. Murai N, Koga K, Nagamachi S, Nishikawa K, Matsuki K, Kusumoto S, et al. Radiotherapy in bone metastases--with special reference to its effect on relieving pain. Gan No Rinsho. 1989. 35:1149–1152.

20. Yoshikawa K, Kitaoka H. Bone metastasis of gastric cancer. Jpn J Surg. 1983. 13:173–176.

21. McQuay HJ, Collins SL, Carroll D, Moore RA. Radiotherapy for the palliation of painful bone metastases. Cochrane Database Syst Rev. 2000. (2):CD001793.

22. Yasuda K, Kimura T, Seita M, Takahata T, Akazai Y. A case of gastric cancer accompanied by disseminated carcinomatosis of bone marrow with DIC recovered by sequential therapy consisting of MTX and 5-FU. Gan To Kagaku Ryoho. 2008. 35:1941–1943.

23. Migita K, Watanabe A, Sakamoto C, Nakamura T, Ohyama T, Ishikawa H, et al. A case of multiple bone metastases from gastric cancer treated with combination chemotherapy of S-1 and CDDP. Gan To Kagaku Ryoho. 2007. 34:929–931.

24. Fujishima Y, Yoneda R, Iwai M, Fukunaga H, Miura M, Koide M, et al. A case of advanced gastric cancer with disseminated carcinomatosis of bone marrow treated by S-1 and CDDP. Gan To Kagaku Ryoho. 2009. 36:2653–2655.

25. Berenson JR, Rosen LS, Howell A, Porter L, Coleman RE, Morley W, et al. Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases. Cancer. 2001. 91:1191–1200.

26. Carano A, Teitelbaum SL, Konsek JD, Schlesinger PH, Blair HC. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest. 1990. 85:456–461.

27. Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res. 1995. 10:1478–1487.

28. Chung YS, Choi TY, Ha CY, Kim HM, Lee KJ, Park CH, et al. An unusual case of osteoblastic metastasis from gastric carcinoma. Yonsei Med J. 2002. 43:377–380.